Abstract

Following a period of unprecedented reductions in malaria incidence and mortality, the WHO reported in 2017 that progress has stalled and even reversed in some regions. This sobering report underscores how the scientific community must continually renew its commitment to malaria eradication, while also striving to improve the care of patients and populations who will continue to suffer until eradication is achieved. The focus of this meeting is cutting-edge clinical and translational research, that aims to improve patient outcomes, decrease the malaria burden in communities and accelerate elimination efforts. The GRS will provide a unique opportunity for early career researchers to present and discuss new data and exchange cutting edge ideas among peers. To stimulate this interaction, speakers and poster presentations are expected to share unpublished data in the pathophysiology and treatment of malaria, drug resistance and drug development, vaccines and immunology, vector control, biology and epidemiology of asymptomatic infections, dynamics of transmission and novel implementation of existing tools in the field. All participants will have the opportunity to present their data in either poster format or short talk, and discussions will be facilitated by selected junior scientist discussion leaders and senior scientist mentors.